| Project PLUS Lung Cancer Screening Promotion (NCT05937399) | Abramson Cancer Center at Penn Medicine | 2022-12-02 |
| Predictive Analytics and Behavioral Nudges to Improve Palliative Care in Advanced Cancer (NCT05590962) | Abramson Cancer Center at Penn Medicine | 2022-11-09 |
| Vaccine Responses in Cancer (NCT06605625) | Abramson Cancer Center at Penn Medicine | 2022-11-04 |
| Understanding Quality of Life Among Patients With Cancer Receiving Palliative Care (NCT05331625) | Abramson Cancer Center at Penn Medicine | 2022-11-03 |
| Head Stabilization of Healthy Volunteers (NCT07116759) | Abramson Cancer Center at Penn Medicine | 2022-10-09 |
| Role of the Immune Environment in Response to Therapy in Breast Cancer (NCT05396612) | Abramson Cancer Center at Penn Medicine | 2022-10-03 |
| eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (NCT05427240) | Abramson Cancer Center at Penn Medicine | 2022-09-28 |
| Project RESIST: Evaluating the Effects of Anti-smoking Inoculation Messages Among Young Adult Sexual Minority Women (NCT05499520) | Abramson Cancer Center at Penn Medicine | 2022-09-21 |
| SBRT With Atezo/Bev for HCC (NCT05488522) | Abramson Cancer Center at Penn Medicine | 2022-09-01 |
| RADVAX™ for Relapsed/Refractory Non-Hodgkin Lymphoma: A Phase II Trial of Pembrolizumab + Low Dose Radiotherapy (NCT04827862) | Abramson Cancer Center at Penn Medicine | 2022-07-01 |
| Improving Tobacco Treatment Rates for Cancer Patients Who Smoke (NCT04738643) | Abramson Cancer Center at Penn Medicine | 2022-06-28 |
| Physical Activity in Rectal Cancer Survivors (NCT06435975) | Abramson Cancer Center at Penn Medicine | 2022-06-01 |
| Multimodality MRI and Liquid Biopsy in GBM (NCT04776980) | Abramson Cancer Center at Penn Medicine | 2022-06-01 |
| OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer (NCT04941378) | Abramson Cancer Center at Penn Medicine | 2022-05-28 |
| Mailed FIT Outreach 2022 (NCT05341622) | Abramson Cancer Center at Penn Medicine | 2022-05-27 |
| Behavioral Nudges to Improve Palliative Care Utilization in Advanced Cancer (NCT05365997) | Abramson Cancer Center at Penn Medicine | 2022-05-23 |
| Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer Prevention (NCT05338307) | Abramson Cancer Center at Penn Medicine | 2022-05-13 |
| RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR) (NCT05176756) | Abramson Cancer Center at Penn Medicine | 2022-04-14 |
| XmAb20717 in Advanced Biliary Tract Cancers (NCT05297903) | Abramson Cancer Center at Penn Medicine | 2022-04-11 |
| Improving Colorectal Cancer Screening in Racially Diverse Zip Codes Using Navigation and Machine Learning (PCSNaP) (NCT05383976) | Abramson Cancer Center at Penn Medicine | 2022-03-29 |
| Comparing Two Ways to Manage Head and Neck Lymphedema (NCT05182229) | Abramson Cancer Center at Penn Medicine | 2022-03-11 |
| Acute Effects of Cigarette Packaging and Charcoal Filtration on Perceptions, Use Behaviors, and Harm Exposure (NCT05157048) | Abramson Cancer Center at Penn Medicine | 2022-03-10 |
| Zr89 + PET Companion Trial (NCT05279027) | Abramson Cancer Center at Penn Medicine | 2022-03-08 |
| Assessing the Impact of a Financial Navigation Program for Patients With Multiple Myeloma (NCT05448196) | Abramson Cancer Center at Penn Medicine | 2022-03-04 |
| TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC) (NCT04873895) | Abramson Cancer Center at Penn Medicine | 2022-01-24 |
| Endodontic-Restorative Pre-Radiation Therapy of Head and Neck Cancer Patients (NCT04996641) | Abramson Cancer Center at Penn Medicine | 2022-01-03 |
| Text-based Intervention to Minimize the Time Burden of Routine Cancer Care (NCT05134636) | Abramson Cancer Center at Penn Medicine | 2021-12-06 |
| CAR-T Followed by Bispecific Antibodies (NCT04889716) | Abramson Cancer Center at Penn Medicine | 2021-11-05 |
| ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer (NCT04523857) | Abramson Cancer Center at Penn Medicine | 2021-11-01 |
| Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting (NCT04711473) | Abramson Cancer Center at Penn Medicine | 2021-10-27 |
| Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer (NCT05096338) | Abramson Cancer Center at Penn Medicine | 2021-10-27 |
| Breast Cancer Outreach Among Primary Care Patients (NCT05089903) | Abramson Cancer Center at Penn Medicine | 2021-10-25 |
| Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer (NCT05078190) | Abramson Cancer Center at Penn Medicine | 2021-10-21 |
| CapTemY90 for Grade 2/3 NET Liver Metastases (NCT04339036) | Abramson Cancer Center at Penn Medicine | 2021-10-07 |
| Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts (NCT04854304) | Abramson Cancer Center at Penn Medicine | 2021-09-23 |
| STEP Together: An Effectiveness-Implementation Study of Social Incentives and Physical Activity (NCT04942535) | Abramson Cancer Center at Penn Medicine | 2021-09-21 |
| Effect of Behavioral Nudges on Serious Illness Conversation Documentation (NCT04867850) | Abramson Cancer Center at Penn Medicine | 2021-09-09 |
| Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches (NCT04812795) | Abramson Cancer Center at Penn Medicine | 2021-09-08 |
| Low-Level Laser in Head and Neck Chronic Lymphedema (NCT04482855) | Abramson Cancer Center at Penn Medicine | 2021-08-19 |
| 'Penny', a SMS Text-based Chatbot Intervention for Medication Adherence and Side Effect Management Among Patients With GI Cancers (NCT05113264) | Abramson Cancer Center at Penn Medicine | 2021-08-02 |
| Telehealth Weight Loss Program for Breast Cancer Survivors (NCT04855552) | Abramson Cancer Center at Penn Medicine | 2021-07-19 |
| Palliative Care Outcomes in the Management of Malignant Ascites by Interventional Radiology (NCT02477657) | Abramson Cancer Center at Penn Medicine | 2021-07-01 |
| Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer (NCT04841148) | Abramson Cancer Center at Penn Medicine | 2021-06-01 |
| Young Adults' Reactions to Low Nicotine Cigarette Advertising (NCT04906148) | Abramson Cancer Center at Penn Medicine | 2021-05-27 |
| Improving Tobacco Treatment Rates for Outpatient Cancer Patients Who Smoke (NCT04737031) | Abramson Cancer Center at Penn Medicine | 2021-05-18 |
| Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening (NCT04798664) | Abramson Cancer Center at Penn Medicine | 2021-05-17 |
| BAPS in Botswana: The Thotloetso Trial (NCT04532970) | Abramson Cancer Center at Penn Medicine | 2021-05-06 |
| Effectiveness of MyCancerGene to Optimize Genetic Testing Outcomes (NCT04774445) | Abramson Cancer Center at Penn Medicine | 2021-05-03 |
| Long Term Arrhythmia Risk and Cardiovascular Events in Hematopoietic Stem Cell Transplant (NCT04118530) | Abramson Cancer Center at Penn Medicine | 2021-04-21 |
| INO 5401 Vaccination in BRCA1/2 Mutation Carriers (NCT04367675) | Abramson Cancer Center at Penn Medicine | 2021-04-20 |
| Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer (NCT04735068) | Abramson Cancer Center at Penn Medicine | 2021-04-09 |
| Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (NCT04736472) | Abramson Cancer Center at Penn Medicine | 2021-03-26 |
| Pilot Study of an NTproBNP Guided Strategy of Cardioprotection (NCT04737265) | Abramson Cancer Center at Penn Medicine | 2021-03-18 |
| CTNNA1 Familial Expansion Study (NCT05126290) | Abramson Cancer Center at Penn Medicine | 2021-03-16 |
| Implementation Strategies for Monitoring Adherence in Real Time (NCT04347161) | Abramson Cancer Center at Penn Medicine | 2021-02-22 |
| India HIV-CervCa Project (NCT07167069) | Abramson Cancer Center at Penn Medicine | 2021-02-09 |
| An Analysis of Medication Adherence Using Televideo and Telephonic Monitoring and Utilization of an Education Protocol (NCT06696521) | Abramson Cancer Center at Penn Medicine | 2021-02-09 |
| Functional Lung Imaging With DECT and 4DCT (NCT04702607) | Abramson Cancer Center at Penn Medicine | 2021-01-02 |
| A Study of Entinostat and FOLFOX in Subjects With Pancreatic Adenocarcinoma (NCT03760614) | Abramson Cancer Center at Penn Medicine | 2021-01-01 |
| FDA Cigarette Warning Labels: Eye Tracking Study (NCT04936724) | Abramson Cancer Center at Penn Medicine | 2020-12-22 |
| BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy (NCT04454528) | Abramson Cancer Center at Penn Medicine | 2020-12-07 |
| PROStep: A Feasibility Trial Using PROs and Step Data to Monitor Patients With Lung and GI Cancers (NCT04616768) | Abramson Cancer Center at Penn Medicine | 2020-11-19 |
| A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects (NCT04288687) | Abramson Cancer Center at Penn Medicine | 2020-10-19 |
| HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer (NCT03685331) | Abramson Cancer Center at Penn Medicine | 2020-10-15 |
| The Association Between CBT-I Dose and Innate Immunity in Insomnia and Fatigue in Prostate Cancer Patients (NCT06604247) | Abramson Cancer Center at Penn Medicine | 2020-09-30 |
| Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy (NCT04305613) | Abramson Cancer Center at Penn Medicine | 2020-09-14 |
| Nivolumab + Ipilimumab With Immunostimulatory Embolization for Stage 4 Renal Cell Carcinoma With Unresected Primary (NCT04429321) | Abramson Cancer Center at Penn Medicine | 2020-08-26 |
| Physiologic MR Imaging of Salivary Gland Tumors (NCT04452162) | Abramson Cancer Center at Penn Medicine | 2020-08-25 |
| Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Metastatic Cancer Patients (NCT04353973) | Abramson Cancer Center at Penn Medicine | 2020-08-17 |
| Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance (NCT04332367) | Abramson Cancer Center at Penn Medicine | 2020-08-01 |
| Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study (NCT04361240) | Abramson Cancer Center at Penn Medicine | 2020-08-01 |
| A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer (NCT03519308) | Abramson Cancer Center at Penn Medicine | 2020-07-29 |
| Cigar Packaging Study (NCT04605874) | Abramson Cancer Center at Penn Medicine | 2020-03-05 |
| Penn Biobank Return of Research Results Program (NCT04242667) | Abramson Cancer Center at Penn Medicine | 2020-03-01 |
| Autoimmunity After Checkpoint Blockade (NCT04119713) | Abramson Cancer Center at Penn Medicine | 2020-02-24 |
| Adjuvant Treatment Determined By Pathological Response To Neoadjvuant Nivolumab (NCT04013854) | Abramson Cancer Center at Penn Medicine | 2020-01-01 |
| MRI Effects of Pegvorhyaluronidase Alfa (PEGPH20) in Pancreatic Ductal Adenocarcinoma (NCT04134468) | Abramson Cancer Center at Penn Medicine | 2020-01-01 |
| Niraparib/TTFields in GBM (NCT04221503) | Abramson Cancer Center at Penn Medicine | 2019-12-30 |
| GeoScan and Remote Geo Smoking Study: Neural and Behavioral Correlates of Smokers' Exposure to Retail Environments (NCT04279483) | Abramson Cancer Center at Penn Medicine | 2019-12-17 |
| PDT Plus Vitamin D3 for Anal Dysplasia (NCT02698293) | Abramson Cancer Center at Penn Medicine | 2019-12-01 |
| BRCA1/2 Flu Vaccine (NCT04499534) | Abramson Cancer Center at Penn Medicine | 2019-10-28 |
| Li-Fraumeni Syndrome/TP53 Biobank (NCT04367246) | Abramson Cancer Center at Penn Medicine | 2019-09-24 |
| Cigarette Packaging of Low Nicotine Cigarettes (NCT03802019) | Abramson Cancer Center at Penn Medicine | 2019-09-18 |
| Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab (NCT04023110) | Abramson Cancer Center at Penn Medicine | 2019-08-09 |
| Ostomy Rural Telehealth Training Cancer Survivors (NCT03913715) | Abramson Cancer Center at Penn Medicine | 2019-08-01 |
| Abemaciclib and Nivolumab for Subjects With Hepatocellular Carcinoma (NCT03781960) | Abramson Cancer Center at Penn Medicine | 2019-07-31 |
| Cardiovascular Effects of CART Cell Therapy (NCT04026737) | Abramson Cancer Center at Penn Medicine | 2019-07-22 |
| A Trial of Behavioral Economic Interventions Among Food Pantry Clients (NCT04011384) | Abramson Cancer Center at Penn Medicine | 2019-07-05 |
| Neoadjuvant PD-1 Blockade in Patients with Stage IIB/C Melanoma (NCT03757689) | Abramson Cancer Center at Penn Medicine | 2019-05-06 |
| [18F] F-GLN by PET/CT in Breast Cancer (NCT03863457) | Abramson Cancer Center at Penn Medicine | 2019-04-05 |
| Pembrolizumab in Relapsed or Refractory Extranodal NK/T- Cell Lymphoma, Nasal Type and EBV-associated Diffuse Large B Cell Lymphomas (NCT03586024) | Abramson Cancer Center at Penn Medicine | 2019-03-12 |
| Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer (NCT03546829) | Abramson Cancer Center at Penn Medicine | 2019-03-05 |
| Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER") (NCT03400254) | Abramson Cancer Center at Penn Medicine | 2019-02-26 |
| Nivolumab and Ipilimumab in Mucinous Colorectal and Appendiceal Tumors (NCT03693846) | Abramson Cancer Center at Penn Medicine | 2019-02-15 |
| Lung Heart Rate Variability (NCT03674450) | Abramson Cancer Center at Penn Medicine | 2019-01-02 |
| Yoga for Solid Tumor (NCT03728205) | Abramson Cancer Center at Penn Medicine | 2018-12-15 |
| Cardiovascular Function in Acute Leukemia (NCT03760237) | Abramson Cancer Center at Penn Medicine | 2018-12-10 |
| Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma (NCT03646617) | Abramson Cancer Center at Penn Medicine | 2018-11-27 |
| Lymphoma RadVax LYMPHOMA: A PHASE II TRIAL OF NIVOLUMAB + LOW DOSE RADIOTHERAPY FOR INCOMPLETE RESPONDERS (NCT03495713) | Abramson Cancer Center at Penn Medicine | 2018-11-02 |
| Buddy Relationships in DermatoloGic Excisions for Skin Cancer (NCT04036344) | Abramson Cancer Center at Penn Medicine | 2018-10-12 |